Back to Awarded Treatment Trials
Awarded Trial: 01T-432
Grant ID
01T-432
Illness
Schizophrenia
Primary Drug/Intervention
Riluzole
Primary Dosage
50mg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Zimolo
Sample Size
30
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
PANSS, CGI, Cognitive Battery
Results
Twenty patients completed the study. There were no significant differences between drug and placebo.
Publication
N/A
Link
N/A
PI Name
Zoran Zimolo
Degree
MD
Center
Department of Psychiatry
Institution
Yale University School of Medicine
Address
950 Campbell Ave
City or Town
New Haven
State or Province
CT
Zip or Postal Code
6516
Country
USA
Email Address
zoran.zimolo@yale.edu